Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH

Pathology Research and Practice

Volumn 209, Issue 7, 2013, Pages 429-432

  Erkan, Gulbanu ^a   Yilmaz, Guldal ^b   Konca Degertekin, Ceyla ^b   Akyol, Gulen ^b   Ozenirler, Seren ^b  

^a UFUK UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Estrogen receptor alpha; Nonalcoholic steatohepatitis; Simple steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ESTROGEN RECEPTOR ALPHA; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PROTEIN EXPRESSION; SCORING SYSTEM;

ESTROGEN RECEPTOR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; SIMPLE STEATOSIS;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BIOPSY; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL NUCLEUS; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FASTING; FATTY LIVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84880043030     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2013.04.010     Document Type: Article

References (17)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2009, 32(Suppl. 1):62-67.
2. Chow J.D., Jones M.E., Prelle K., Simpson E.R., Boon W.C. A selective estrogen receptor α agonist ameliorates hepatic steatosis in the male aromatase knockout mouse. J. Endocrinol. 2011, 210(3):323-334.
3. Gutierrez-Grobe Y., Ponciano-Rodríguez G., Ramos M.H., Uribe M., Méndez-Sánchez N. Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens. Ann. Hepatol. 2010, 9(4):402-409.
4. Kamada Y., Kiso S., Yoshida Y., Chatani N., Kizu T., Hamano M., Tsubakio M., Takemura T., Ezaki H., Hayashi N., Takehara T. Estrogen deficiency worsens steatohepatitis in mice fed high-fat and high-cholesterol diet. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301(6):1031-1043.
5. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Nonalcoholic steatohepatitis clinical research network, design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41(6):1313-1321.
6. Loomba R., Abraham M., Unalp A., Wilson L., Lavine J., Doo E., Bass N.M. Association between diabetes, family history of diabetes and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology 2012, 56(3):943-951. NASH Clinical Research Network.
7. Ludwig J., Viggiano T.R., McGill D.B., Oh B.J. Nonalcoholic steatohepatitis: Mayo clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 1980, 55:434-438.
8. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda N., Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37(4):917-923.
9. Nemoto Y., Toda K., Ono M., Fujikawa-Adachi K., Saibara T., Onishi S., Enzan H., Okada T., Shizuta Y. Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J. Clin. Invest. 2000, 105(12):1819-1825.
10. Nilsson S., Mäkelä S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiol. Rev. 2001, 81(4):1535-1565.
11. Ratziu V., Bellentani S., Cortez-Pinto H., Day C., Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol. 2010, 53:372-384.
12. Ribas V., Nguyen M.T., Henstridge D.C., Nguyen A.K., Beaven S.W., Watt M.J., Hevener A.L. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ER alpha-deficient mice. Am. J. Physiol. Endocrinol. Metab. 2010, 298(2):304-319.
13. Saphner T., Triest-Robertson S., Li H., Holzman P. The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancer. Cancer 2009, 115(14):3189-3195.
14. Shimizu I., Kohno N., Tamaki K., Shono M., Huang H.W., He J.H., Yao D.F. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J. Gastroenterol. 2007, 13(32):4295-4305.
15. Weston S.R., Leyden W., Murphy R., Bass N.M., Bell P.B., Manos M.M., Terrault N.A. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005, 41:372-379.
16. Yasuda M., Shimizu I., Shiba M., Ito S. Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 1999, 29(3):719-727.
17. Yatsuji S., Hashimoto E., Tobari M., Tokushige K., Shiratori K. Influence of age and gender in Japanese patients with nonalcoholic steatohepatitis. Hepatol. Res. 2007, 37:1034-1043.